Deng et al. [131] showed that catenin application in colon cancer decreased the transactivation activity and the expression of NF-κB target genes and inhibited the expression of NF-κB target genes, including Fas and TRAF1. The gene discussed is NFKB1; the disease is colonic neoplasm.